4.8 Article

Id proteins at the cross-road of development and cancer

Journal

ONCOGENE
Volume 20, Issue 58, Pages 8326-8333

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1205093

Keywords

cell differentiation; cell cycle; retinoblastoma protein; Id2; neuroblastoma; angiogenesis

Funding

  1. NCI NIH HHS [R01-CA85628] Funding Source: Medline

Ask authors/readers for more resources

A large body of evidence has been, accumulated that demonstrates dominant effects of Id proteins on different aspects of cellular growth. Generally, constitutive expression of Id not only blocks cell differentiation but also drives proliferation. In some settings, it is sufficient to render cells immortal or induce oncogenic transformation. The participation of Id proteins in advanced human malignancy, where they are frequently deregulated, has been dramatically bolstered by the recent discovery that Id exert pivotal contributions to many of the essential alterations that collectively dictate malignant growth. Relentless proliferation associated with self-sufficiency in growth signals and insensitivity to growth inhibitory signals, sustained neoangiogenesis, tissue invasiveness and migration capabilities of tumor cells all share dependency on the unlimited availability of Id proteins. It is remarkable that many of these features recapitulate those physiologically propelled by Id proteins to support normal development. We propose that the participation of Id in multiple fundamental traits of cancer may be the basis for unprecedented therapeutic opportunities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available